Myocardial inflammation in myocarditis: mechanisms and therapeutic targets
Frontiers in Cardiovascular Medicine · 23.06.2026 · 13
DOI: 10.3389/fcvm.2026.1821475 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 23.06.2026. Verfasst von Cristina Madaudo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo, Palermo, Italy. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myocarditis is an inflammatory disease of the myocardium with heterogeneous aetiologies, in which innate and adaptive immune responses critically influence clinical outcomes, ranging from complete recovery to progression toward dilated cardiomyopathy. In viral myocarditis, pathogen- and damage-associated molecular patterns activate pattern-recognition receptors, triggering NF- κ B and inflammasome signaling and amplifying pro-inflammatory cytokine responses. Early myocardial injury involves neutrophils, mast cells, natural killer cells, and inflammatory monocytes, followed by activation of adaptive immune responses. Imbalance of Th1/Th2 immunity and dysregulation of the Th17/Treg axis promote persistent inflammation and fibrotic remodeling. Autoimmune mechanisms driven by molecular mimicry, pathogenic autoantibodies, and genetic susceptibility further sustain myocardial injury. While conventional biomarkers support diagnosis, emerging inflammatory markers and immune-derived indices show promise for risk stratification and disease monitoring. Beyond guideline-directed heart failure therapy, targeted immunomodulatory strategies are under investigation, highlighting the need for precision approaches to prevent chronic inflammation and adverse remodeling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (ProMISE), University of Palermo, Palermo, Italy.
- Division of Cardiology, University Hospital P. Giaccone, University of Palermo, Palermo, Italy.
- Department of Clinical Cardiology and Heart Failure, Mediterranean Institute for Transplantation and Advanced Specialized Therapies, IRCCS ISMETT, UPMC, Palermo, Italy.
Zitieren
APA
Madaudo, C., Di Lisi, D., Macaione, F., Nuzzi, V., Micarelli, A., Sausa, G., Castelli, G., Corrado, E., Galassi, A. R., & Novo, G. (2026). Myocardial inflammation in myocarditis: mechanisms and therapeutic targets. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1821475
Vancouver
Madaudo C, Di Lisi D, Macaione F, Nuzzi V, Micarelli A, Sausa G, et al. Myocardial inflammation in myocarditis: mechanisms and therapeutic targets. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1821475
BibTeX
@article{Madaudo2026,
author = {Madaudo, Cristina and Di Lisi, Daniela and Macaione, Francesca and Nuzzi, Vincenzo and Micarelli, Andrea and Sausa, Giusy and Castelli, Giovanni and Corrado, Egle and Galassi, Alfredo Ruggero and Novo, Giuseppina},
title = {Myocardial inflammation in myocarditis: mechanisms and therapeutic targets},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1821475}
}
EUVIMED